BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 29861492)

  • 1. Prioritization of Variants Detected by Next Generation Sequencing According to the Mutation Tolerance and Mutational Architecture of the Corresponding Genes.
    Roca I; Fernández-Marmiesse A; Gouveia S; Segovia M; Couce ML
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29861492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical validation of targeted next-generation sequencing for inherited disorders.
    Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B
    Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leveraging network analytics to infer patient syndrome and identify causal genes in rare disease cases.
    Krämer A; Shah S; Rebres RA; Tang S; Richards DR
    BMC Genomics; 2017 Aug; 18(Suppl 5):551. PubMed ID: 28812537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VarSight: prioritizing clinically reported variants with binary classification algorithms.
    Holt JM; Wilk B; Birch CL; Brown DM; Gajapathy M; Moss AC; Sosonkina N; Wilk MA; Anderson JA; Harris JM; Kelly JM; Shaterferdosian F; Uno-Antonison AE; Weborg A; ; Worthey EA
    BMC Bioinformatics; 2019 Oct; 20(1):496. PubMed ID: 31615419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mirTrios: an integrated pipeline for detection of de novo and rare inherited mutations from trios-based next-generation sequencing.
    Li J; Jiang Y; Wang T; Chen H; Xie Q; Shao Q; Ran X; Xia K; Sun ZS; Wu J
    J Med Genet; 2015 Apr; 52(4):275-81. PubMed ID: 25596308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation sequencing applied to rare diseases genomics.
    Danielsson K; Mun LJ; Lordemann A; Mao J; Lin CH
    Expert Rev Mol Diagn; 2014 May; 14(4):469-87. PubMed ID: 24702023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility in infants with suspected monogenic conditions through next-generation sequencing.
    Hong S; Wang L; Zhao D; Zhang Y; Chen Y; Tan J; Liang L; Zhu T
    Mol Genet Genomic Med; 2019 Jun; 7(6):e684. PubMed ID: 30968598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of Primary Ciliary Dyskinesia by a Targeted Next-Generation Sequencing Panel: Molecular and Clinical Findings in Italian Patients.
    Boaretto F; Snijders D; Salvoro C; Spalletta A; Mostacciuolo ML; Collura M; Cazzato S; Girosi D; Silvestri M; Rossi GA; Barbato A; Vazza G
    J Mol Diagn; 2016 Nov; 18(6):912-922. PubMed ID: 27637300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted next-generation sequencing detects novel gene-phenotype associations and expands the mutational spectrum in cardiomyopathies.
    Forleo C; D'Erchia AM; Sorrentino S; Manzari C; Chiara M; Iacoviello M; Guaricci AI; De Santis D; Musci RL; La Spada A; Marangelli V; Pesole G; Favale S
    PLoS One; 2017; 12(7):e0181842. PubMed ID: 28750076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. eDiVA-Classification and prioritization of pathogenic variants for clinical diagnostics.
    Bosio M; Drechsel O; Rahman R; Muyas F; Rabionet R; Bezdan D; Domenech Salgado L; Hor H; Schott JJ; Munell F; Colobran R; Macaya A; Estivill X; Ossowski S
    Hum Mutat; 2019 Jul; 40(7):865-878. PubMed ID: 31026367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of deep intronic variants in 15 haemophilia A patients by next generation sequencing of the whole factor VIII gene.
    Bach JE; Wolf B; Oldenburg J; Müller CR; Rost S
    Thromb Haemost; 2015 Oct; 114(4):757-67. PubMed ID: 25948085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical assessment of variant prioritization methods for rare disease diagnosis within the rare genomes project.
    Stenton SL; O'Leary MC; Lemire G; VanNoy GE; DiTroia S; Ganesh VS; Groopman E; O'Heir E; Mangilog B; Osei-Owusu I; Pais LS; Serrano J; Singer-Berk M; Weisburd B; Wilson MW; Austin-Tse C; Abdelhakim M; Althagafi A; Babbi G; Bellazzi R; Bovo S; Carta MG; Casadio R; Coenen PJ; De Paoli F; Floris M; Gajapathy M; Hoehndorf R; Jacobsen JOB; Joseph T; Kamandula A; Katsonis P; Kint C; Lichtarge O; Limongelli I; Lu Y; Magni P; Mamidi TKK; Martelli PL; Mulargia M; Nicora G; Nykamp K; Pejaver V; Peng Y; Pham THC; Podda MS; Rao A; Rizzo E; Saipradeep VG; Savojardo C; Schols P; Shen Y; Sivadasan N; Smedley D; Soru D; Srinivasan R; Sun Y; Sunderam U; Tan W; Tiwari N; Wang X; Wang Y; Williams A; Worthey EA; Yin R; You Y; Zeiberg D; Zucca S; Bakolitsa C; Brenner SE; Fullerton SM; Radivojac P; Rehm HL; O'Donnell-Luria A
    Hum Genomics; 2024 Apr; 18(1):44. PubMed ID: 38685113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes.
    Paulo P; Pinto P; Peixoto A; Santos C; Pinto C; Rocha P; Veiga I; Soares G; Machado C; Ramos F; Teixeira MR
    J Mol Diagn; 2017 Jul; 19(4):502-513. PubMed ID: 28529006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designs for massively parallel sequencing approaches to identify causal mutations in human immune disorders.
    Zhang Y; Su HC
    Methods Mol Biol; 2013; 979():175-87. PubMed ID: 23397396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and Quantification of Mosaic Mutations in Disease Genes by Next-Generation Sequencing.
    Qin L; Wang J; Tian X; Yu H; Truong C; Mitchell JJ; Wierenga KJ; Craigen WJ; Zhang VW; Wong LC
    J Mol Diagn; 2016 May; 18(3):446-453. PubMed ID: 26944031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Explicable prioritization of genetic variants by integration of rule-based and machine learning algorithms for diagnosis of rare Mendelian disorders.
    Kim HH; Kim DW; Woo J; Lee K
    Hum Genomics; 2024 Mar; 18(1):28. PubMed ID: 38509596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taking the next step forward - Diagnosing inherited infantile cholestatic disorders with next generation sequencing.
    Herbst SM; Schirmer S; Posovszky C; Jochum F; Rödl T; Schroeder JA; Barth TF; Hehr U; Melter M; Vermehren J
    Mol Cell Probes; 2015 Oct; 29(5):291-8. PubMed ID: 25771912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational profiling in the peripheral blood leukocytes of patients with systemic mast cell activation syndrome using next-generation sequencing.
    Altmüller J; Haenisch B; Kawalia A; Menzen M; Nöthen MM; Fier H; Molderings GJ
    Immunogenetics; 2017 Jun; 69(6):359-369. PubMed ID: 28386644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xrare: a machine learning method jointly modeling phenotypes and genetic evidence for rare disease diagnosis.
    Li Q; Zhao K; Bustamante CD; Ma X; Wong WH
    Genet Med; 2019 Sep; 21(9):2126-2134. PubMed ID: 30675030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.